RxDoctor Payments Data

Anthony Killeen, MD

Clinical Pathology/Laboratory Medicine · Minneapolis, MNNPI 1811087323

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,556 of the $3,149 with a category attached, or 81.2%. Abbott accounts for 93.0% of it on its own, with 1 other manufacturer making up the rest.

$3,149in general payments, 2019–2025

Across 9 payments — averaging $349.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Roche Diagnostics Corporation$221
$90,009in research payments, 2019–2025

Across 4 payments — averaging $22,502 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Insulet Corporation$75K
  • Diasorin Inc.$15K

What the payments were for

  • Travel & lodging$2,55681%
  • Food & beverage$59219%

General payments by program year

23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott8$2,928
Roche Diagnostics Corporation1$221

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,149 in reported general payments places this provider in the 75th percentile of 30 clinical pathology/laboratory medicine providers in Minnesota.

See all clinical pathology/laboratory medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$137,006
Medicare patients
1,202
Services billed
7,993

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical pathology/laboratory medicine in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →